Kezar Life Sciences, Inc.

Historical 13F Holders

Symbol
KZR
CUSIP
49372L100
All holders as of
Q3 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 49372L100 since 12/18/2024, largest first.

Filer % of Class Filed
Equal Talent Investments Ltd 13D/A
8.7% 3/3/2025
Event 2/28/2025
Morningside Venture Investments Ltd 13D/A
8.5% 1/16/2025
Event 12/3/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Avidity Partners Management LP 13G/A
6.9%
Checked 5% or less
2/14/2025
Event 12/31/2024
BML Investment Partners, L.P. 13G/A 0% 5/12/2026
Event 5/11/2026
Barclays PLC 13G/A
Checked 5% or less
3/21/2025
Event 9/30/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q3 59 37.7 M $30.6M
2024 Q2 82 39.5 M $23.7M
2024 Q1 87 44.9 M $40.5M
2023 Q4 83 49.5 M $46.9M
2023 Q3 83 55.5 M $66.0M
2023 Q2 105 56.9 M $139M
2023 Q1 140 60.1 M $188M
2022 Q4 124 57.4 M $404M
2022 Q3 133 57.5 M $495M
2022 Q2 130 54.9 M $454M
2022 Q1 125 44.2 M $734M
2021 Q4 109 40.4 M $674M
2021 Q3 77 28.1 M $243M
2021 Q2 76 27.6 M $150M
2021 Q1 84 26.6 M $158M
2020 Q4 78 23.5 M $123M
2020 Q3 79 23.2 M $112M
2020 Q2 87 23.2 M $120M
2020 Q1 60 18.5 M $80.6M
2019 Q4 56 9.17 M $36.8M
2019 Q3 55 9.43 M $30.9M
2019 Q2 55 10.0 M $77.2M
2019 Q1 51 9.92 M $176M
2018 Q4 41 9.34 M $220M
2018 Q3 38 9.06 M $194M
2018 Q2 27 8.16 M $141M